Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
Overview
Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.
Study Type
- Study Type: Interventional
Interventions
- Genetic: genetic analyzer
Arms, Groups and Cohorts
- No Intervention: Lifestyle counseling
Participating in This Clinical Trial
Inclusion Criteria
- T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL). – DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography. – All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography. Exclusion Criteria:
- Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.
Gender Eligibility: All
Minimum Age: 45 Years
Maximum Age: 74 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Tianjin Medical University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.